» Articles » PMID: 25802822

Neurotrophic Factors and Their Effects in the Treatment of Multiple Sclerosis

Overview
Journal Adv Biomed Res
Date 2015 Mar 25
PMID 25802822
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Neurotrophins are small molecules of polypeptides, which include nerve growth factor (NGF) family, glial cell line-derived neurotrophic factor (GDNF) family ligands, and neuropoietic cytokines. These factors have an important role in neural regeneration, remyelination, and regulating the development of the peripheral and central nervous systems (PNS and CNS, respectively) by intracellular signaling through specific receptors. It has been suggested that the pathogenesis of human neurodegenerative disorders may be due to an alteration in the neurotrophic factors and their receptors. The use of neurotrophic factors as therapeutic agents is a novel strategy for restoring and maintaining neuronal function during neurodegenerative disorders such as multiple sclerosis. Innate and adaptive immune responses contribute to pathology of neurodegenerative disorders. Furthermore, autoimmune and mesenchymal stem cells, by the release of neurotrophic factors, have the ability to protect neuronal population and can efficiently suppress the formation of new lesions. So, these cells may be an alternative source for delivering neurotrophic factors into the CNS.

Citing Articles

Exploring the underlying mechanisms of exercise as therapy for multiple sclerosis: insights from preclinical studies.

Du Y, Dong S, Zou W Front Cell Neurosci. 2024; 18:1460262.

PMID: 39479523 PMC: 11521911. DOI: 10.3389/fncel.2024.1460262.


Fecal microbiota transplantation alters the proteomic landscape of inflammation in HIV: identifying bacterial drivers.

Diaz-Garcia C, Moreno E, Talavera-Rodriguez A, Martin-Fernandez L, Gonzalez-Bodi S, Martin-Pedraza L Microbiome. 2024; 12(1):214.

PMID: 39438902 PMC: 11494993. DOI: 10.1186/s40168-024-01919-5.


MIND Diet Impact on Multiple Sclerosis Patients: Biochemical Changes after Nutritional Intervention.

Navarrete-Perez A, Gomez-Melero S, Escribano B, Galvao-Carmona A, Conde-Gavilan C, Pena-Toledo M Int J Mol Sci. 2024; 25(18).

PMID: 39337497 PMC: 11431943. DOI: 10.3390/ijms251810009.


Fraction of venom containing crotapotin protects PC12 cells against MPP toxicity by activating the NGF-signaling pathway.

Bernardes C, Lopes Pinheiro E, Ferreira I, Oliveira I, Dos Santos N, Sampaio S J Venom Anim Toxins Incl Trop Dis. 2024; 30:e20230056.

PMID: 38915449 PMC: 11194915. DOI: 10.1590/1678-9199-JVATITD-2023-0056.


NGF, EPO, and IGF-1 in the Male Reproductive System.

Metallinou C, Staneloudi C, Nikolettos K, Asimakopoulos B J Clin Med. 2024; 13(10).

PMID: 38792459 PMC: 11122040. DOI: 10.3390/jcm13102918.


References
1.
Rankin S, Guy C, Mearow K . TrkA NGF receptor plays a role in the modulation of p75NTR expression. Neurosci Lett. 2005; 383(3):305-10. DOI: 10.1016/j.neulet.2005.04.043. View

2.
Lindfors P, Lindahl M, Rossi J, Saarma M, Airaksinen M . Ablation of persephin receptor glial cell line-derived neurotrophic factor family receptor alpha4 impairs thyroid calcitonin production in young mice. Endocrinology. 2006; 147(5):2237-44. DOI: 10.1210/en.2005-1620. View

3.
Caggiula M, Batocchi A, Frisullo G, Angelucci F, Patanella A, Sancricca C . Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy. Clin Immunol. 2005; 118(1):77-82. DOI: 10.1016/j.clim.2005.09.005. View

4.
Schonrock L, Gawlowski G, Bruck W . Interleukin-6 expression in human multiple sclerosis lesions. Neurosci Lett. 2000; 294(1):45-8. DOI: 10.1016/s0304-3940(00)01543-3. View

5.
Linker R, Lee D, Demir S, Wiese S, Kruse N, Siglienti I . Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. Brain. 2010; 133(Pt 8):2248-63. DOI: 10.1093/brain/awq179. View